APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 217 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $8,692,215 | +13.5% | 95,414 | -17.8% | 0.03% | +17.2% |
Q1 2023 | $7,660,594 | +123.7% | 116,140 | +75.4% | 0.03% | +123.1% |
Q4 2022 | $3,424,546 | -16.8% | 66,226 | +10.0% | 0.01% | -13.3% |
Q3 2022 | $4,114,000 | +164.9% | 60,230 | +75.4% | 0.02% | +114.3% |
Q2 2022 | $1,553,000 | +105.7% | 34,340 | +131.0% | 0.01% | +133.3% |
Q1 2022 | $755,000 | – | 14,866 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |